{"url_path":"/sec/adpt/8-k/2026-06-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1478320/0001193125-26-271117-index.html","accession_number":"0001193125-26-271117","cik":"0001478320","ticker":"ADPT","issuer_name":"Adaptive Biotechnologies Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1478320/0001193125-26-271117-index.html","primary_entity_key":"0001478320","primary_entity_name":"Adaptive Biotechnologies Corp"},"word_count":91,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\nNumber\n  \n\nDescription\n\n99.1\n  \n[Press Release dated June 15, 2026 (Notes Offering)](d65233dex991.htm)\n\n99.2\n  \n[Press Release dated June 15, 2026 (Business Separation)](d65233dex992.htm)\n\n99.3\n  \n[Company Statement](d65233dex993.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \nAdaptive Biotechnologies Corporation\n\nDate: June 15, 2026\n \n\n \nBy:\n \n\n/s/ Kyle Piskel\n\n \n\n \n\n \nKyle Piskel\n\n \n\n \n\n \nChief Financial Officer"}